Detailed information for compound 132481

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 189.297 | Formula: C13H19N
  • H donors: 0 H acceptors: 0 LogP: 3.04 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCN1CCC(C1)c1ccccc1
  • InChi: 1S/C13H19N/c1-2-9-14-10-8-13(11-14)12-6-4-3-5-7-12/h3-7,13H,2,8-11H2,1H3
  • InChiKey: SUMWVMTWESCBLU-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Serotonin 1a (5-HT1a) receptor Starlite/ChEMBL No references
Rattus norvegicus Serotonin 2 (5-HT2) receptor Starlite/ChEMBL No references
Rattus norvegicus Dopamine D3 receptor Starlite/ChEMBL No references
Rattus norvegicus Dopamine D2 receptor Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus granulosus biogenic amine 5HT receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma mansoni biogenic amine (5HT) receptor Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum Octopamine receptor, putative Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum ko:K04153 5-hydroxytryptamine (serotonin) receptor 1A, putative Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum expressed protein Get druggable targets OG5_133249 All targets in OG5_133249
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma japonicum IPR000276,Rhodopsin-like GPCR superfamily,domain-containing Serotonin 1a (5-HT1a) receptor   422 aa 392 aa 20.7 %
Echinococcus granulosus g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 24.3 %
Schistosoma mansoni muscarinic acetylcholine (GAR) receptor Dopamine D2 receptor   444 aa 487 aa 23.8 %
Echinococcus granulosus g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 23.4 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Serotonin 1a (5-HT1a) receptor   422 aa 448 aa 29.7 %
Schistosoma mansoni amine GPCR Serotonin 1a (5-HT1a) receptor   422 aa 440 aa 31.6 %
Schistosoma japonicum ko:K04145 dopamine receptor D2, putative Serotonin 1a (5-HT1a) receptor   422 aa 410 aa 27.8 %
Echinococcus multilocularis serotonin receptor Dopamine D2 receptor   444 aa 428 aa 31.3 %
Schistosoma japonicum Octopamine receptor 1, putative Serotonin 1a (5-HT1a) receptor   422 aa 424 aa 24.3 %
Echinococcus granulosus orexin receptor type 2 Serotonin 1a (5-HT1a) receptor   422 aa 369 aa 22.0 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Serotonin 1a (5-HT1a) receptor   422 aa 383 aa 30.5 %
Loa Loa (eye worm) hypothetical protein Serotonin 1a (5-HT1a) receptor   422 aa 388 aa 26.5 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 426 aa 29.6 %
Onchocerca volvulus Dopamine D3 receptor   446 aa 462 aa 26.0 %
Loa Loa (eye worm) TYRA-2 protein Serotonin 1a (5-HT1a) receptor   422 aa 491 aa 27.3 %
Echinococcus multilocularis g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 433 aa 22.4 %
Schistosoma japonicum ko:K04207 neuropeptide Y receptor Y5, putative Serotonin 1a (5-HT1a) receptor   422 aa 339 aa 23.0 %
Schistosoma mansoni biogenic amine receptor Dopamine D3 receptor   446 aa 455 aa 28.6 %
Schistosoma mansoni peptide (FMRFamide/neurokinin-3)-like receptor Serotonin 1a (5-HT1a) receptor   422 aa 350 aa 20.6 %
Echinococcus multilocularis biogenic amine (5HT) receptor Dopamine D3 receptor   446 aa 499 aa 30.9 %
Schistosoma japonicum IPR000276,Rhodopsin-like GPCR superfamily,domain-containing Serotonin 1a (5-HT1a) receptor   422 aa 417 aa 21.1 %
Schistosoma mansoni ancient conserved domain protein 2 (cyclin m2) Dopamine D3 receptor   446 aa 463 aa 25.5 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 436 aa 23.9 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 390 aa 33.6 %
Onchocerca volvulus Serotonin 1a (5-HT1a) receptor   422 aa 407 aa 23.3 %
Schistosoma mansoni biogenic amine (dopamine) receptor Dopamine D2 receptor   444 aa 494 aa 26.3 %
Onchocerca volvulus RB1-inducible coiled-coil protein 1 homolog Dopamine D3 receptor   446 aa 478 aa 22.8 %
Echinococcus multilocularis neuropeptides capa receptor Serotonin 1a (5-HT1a) receptor   422 aa 430 aa 20.0 %
Echinococcus multilocularis alpha 1A adrenergic receptor Dopamine D3 receptor   446 aa 473 aa 21.6 %
Schistosoma japonicum Octopamine receptor, putative Dopamine D3 receptor   446 aa 501 aa 28.5 %
Echinococcus multilocularis g protein coupled receptor Serotonin 1a (5-HT1a) receptor   422 aa 432 aa 23.6 %
Schistosoma japonicum ko:K04145 dopamine receptor D2, putative Dopamine D3 receptor   446 aa 463 aa 29.8 %
Echinococcus granulosus biogenic amine 5HT receptor Dopamine D2 receptor   444 aa 429 aa 31.7 %
Onchocerca volvulus Glycoprotein hormone beta 5 homolog Serotonin 1a (5-HT1a) receptor   422 aa 477 aa 24.3 %
Echinococcus multilocularis orexin receptor type 2 Serotonin 1a (5-HT1a) receptor   422 aa 369 aa 22.2 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Serotonin 1a (5-HT1a) receptor   422 aa 444 aa 29.3 %
Echinococcus granulosus alpha 1A adrenergic receptor Serotonin 1a (5-HT1a) receptor   422 aa 452 aa 21.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Onchocerca volvulus 0.0068 0.2973 1
Schistosoma mansoni biogenic amine (5HT) receptor 0.0161 1 1
Brugia malayi Plexin repeat family protein 0.0068 0.2973 0.7608
Echinococcus granulosus plexin a4 0.008 0.3907 0.3907
Echinococcus multilocularis serotonin receptor 0.0161 1 1
Schistosoma mansoni plexin 0.004 0.0839 0.0839
Loa Loa (eye worm) hypothetical protein 0.0161 1 1
Brugia malayi plexin A 0.008 0.3907 1
Loa Loa (eye worm) hypothetical protein 0.004 0.0839 0.0839
Loa Loa (eye worm) plexin A 0.008 0.3907 0.3907
Schistosoma mansoni hypothetical protein 0.004 0.0839 0.0839
Echinococcus multilocularis plexin a4 0.008 0.3907 0.3907
Loa Loa (eye worm) hypothetical protein 0.0068 0.2973 0.2973
Echinococcus multilocularis serotonin receptor 0.0161 1 1
Schistosoma mansoni plexin 0.0068 0.2973 0.2973
Loa Loa (eye worm) hypothetical protein 0.0161 1 1

Activities

Activity type Activity value Assay description Source Reference
clogP = 3.46 Calculated partition coefficient (clogP) ChEMBL. No reference
Control (functional) = 66 % Accumulation of Dihydroxyphenylalanine in striatal region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
Control (functional) = 81 % Accumulation of 5-Hydroxytryptophan in striatal region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
Control (functional) = 83 % Accumulation of 5-Hydroxytryptophan in cortical brain region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
Control (functional) = 92 % Accumulation of 5-Hydroxytryptophan in limbic region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
Control (functional) = 96 % Accumulation of Dihydroxyphenylalanine in limbic region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
Control (functional) = 115 % Locomotor activity, measured for 30 min after injection of drug, administered subcutaneously at 100 umol/kg ChEMBL. No reference
Control (functional) = 130 % Accumulation of Dihydroxyphenylalanine in cortical brain region in rat after injecting drug compound 65 min and NSD 1015 at a dose of 100 mg/kg administered subcutaneously, 30 min before death, tested in vivo ChEMBL. No reference
IC50 (binding) > 1000 nM Inhibitory concentration against [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells ChEMBL. No reference
IC50 (binding) > 1000 nM Inhibitory concentration against [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) = 453 nM Binding affinity against [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) = 453 nM Binding affinity against [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) = 625 nM Binding affinity against [3H]-U-86,170 binding to Dopamine receptor D2 expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) = 625 nM Binding affinity against [3H]-U-86,170 binding to Dopamine receptor D2 expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) > 2500 nM Binding affinity against [3H]-spiperone binding to Dopamine receptor D3 expressed in CHO-K1 cells ChEMBL. No reference
Ki (binding) > 2500 nM Binding affinity against [3H]-spiperone binding to Dopamine receptor D3 expressed in CHO-K1 cells ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.